Research Study

Effect of MD1003 in progressive multiple sclerosis: A randomized double blind placebo controlled study.
Principal Investigator 
Virginia A. Devonshire

Overview

Body Locations and Systems 
Multiple Sclerosis
ClinicalTrials.gov# 
NCT02936037
Status 
Recruiting
Study Start/End 
May 29, 2017 to Dec 31, 2019
Locations 
UBC Hospital
Name/Title 
Karina Grigore, Clinical Research Coordinator
Phone 
604-827-1892
Email Address 
karina.grigore@ubc.ca
Purpose of Study 

The purpose of this study is to demonstrate the superiority of MD1003 over placebo in the disability of patients suffering from progressive multiple sclerosis and especially those with gait impairment

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.